MDM2 and cancer: Considering the physical binding of Mdm2 with several chromatin-associated factors, including E2F1, Tip60 and NBS1 49, downstream effectors of the SET7/9-Mdm2 axis and related pathways should also been investigated to improve our understanding of SET7/9 in the molecular mechanisms of DNA damage in cancer cells.